1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: A Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
2
|
Mou J, Hu T, Wang Z, Chen W, Wang Y and
Zhang W: ATM gene polymorphisms are associated with poor prognosis
of non-small cell lung cancer receiving radiation therapy. Aging
(Albany NY). 12:7465–7479. 2020. View Article : Google Scholar : PubMed/NCBI
|
3
|
Zhou R, Xu T, Nguyen QN, Liu Y, Yang J,
Komaki R, Gomez DR and Liao Z: Radiation dose, local disease
progression, and overall survival in patients with inoperable
non-small cell lung cancer after concurrent chemoradiation therapy.
Int J Radiat Oncol Biol Phys. 100:452–461. 2018. View Article : Google Scholar : PubMed/NCBI
|
4
|
Nasarre C, Roth M, Jacob L, Roth L,
Koncina E, Thien A, Labourdette G, Poulet P, Hubert P, Crémel G, et
al: Peptide-based interference of the transmembrane domain of
neuropilin-1 inhibits glioma growth in vivo. Oncogene.
29:2381–2392. 2010. View Article : Google Scholar : PubMed/NCBI
|
5
|
Roth L, Nasarre C, Dirrig-Grosch S, Aunis
D, Crémel G, Hubert P and Bagnard D: Transmembrane domain
interactions control biological functions of neuropilin-1. Mol Biol
Cell. 19:646–654. 2008. View Article : Google Scholar : PubMed/NCBI
|
6
|
Nakamura F and Goshima Y: Structural and
functional relation of neuropilins. Adv Exp Med Biol. 515:55–69.
2002. View Article : Google Scholar : PubMed/NCBI
|
7
|
Giordano S, Corso S, Conrotto P, Artigiani
S, Gilestro G, Barberis D, Tamagnone L and Comoglio PM: The
semaphorin 4D receptor controls invasive growth by coupling with
Met. Nat Cell Biol. 4:720–724. 2002. View
Article : Google Scholar : PubMed/NCBI
|
8
|
Hong TM, Chen YL, Wu YY, Yuan A, Chao YC,
Chung YC, Wu MH, Yang SC, Pan SH, Shih JY, et al: Targeting
neuropilin 1 as an antitumor strategy in lung cancer. Clin Cancer
Res. 13:4759–4768. 2007. View Article : Google Scholar : PubMed/NCBI
|
9
|
Osada H, Tokunaga T, Nishi M, Hatanaka H,
Abe Y, Tsugu A, Kijima H, Yamazaki H, Ueyama Y and Nakamura M:
Overexpression of the neuropilin 1 (NRP1) gene correlated with poor
prognosis in human glioma. Anticancer Res. 24:547–552.
2004.PubMed/NCBI
|
10
|
Glinka Y, Mohammed N, Subramaniam V, Jothy
S and Prud'homme GJ: Neuropilin-1 is expressed by breast cancer
stem-like cells and is linked to NF-κB activation and tumor sphere
formation. Biochem Biophys Res Commun. 425:775–780. 2012.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Dong JC, Gao H, Zuo SY, Zhang HQ, Zhao G,
Sun SL, Han HL, Jin LL, Shao LH, Wei W and Jin SZ: Neuropilin 1
expression correlates with the radio-resistance of human
non-small-cell lung cancer cells. J Cell Mol Med. 19:2286–2295.
2015. View Article : Google Scholar : PubMed/NCBI
|
12
|
Xiong K, Shao LH, Zhang HQ, Jin L, Wei W,
Dong Z, Zhu YQ, Wu N, Jin SZ and Xue LX: MicroRNA-9 functions as a
tumor suppressor and enhances radio-sensitivity in radio-resistant
A549 cells by targeting neuropilin 1. Oncol Lett. 15:2863–2870.
2018.PubMed/NCBI
|
13
|
Gorski DH and Walsh K: The role of
homeobox genes in vascular remodeling and angiogenesis. Circ Res.
87:865–872. 2000. View Article : Google Scholar : PubMed/NCBI
|
14
|
Kappen C: Developmental patterning as a
quantitative trait: Genetic modulation of the Hoxb6 mutant skeletal
phenotype. PLoS One. 11:e01460192016. View Article : Google Scholar : PubMed/NCBI
|
15
|
Denans N, Iimura T and Pourquie O: Hox
genes control vertebrate body elongation by collinear Wnt
repression. Elife. 4:e043792015. View Article : Google Scholar
|
16
|
Paço A, Aparecida de Bessa Garcia S,
Leitão Castro J, Costa-Pinto AR and Freitas R: Roles of the HOX
proteins in cancer invasion and metastasis. Cancers (Basel).
13:102020. View Article : Google Scholar
|
17
|
Morgan R, Simpson G, Gray S, Gillett C,
Tabi Z, Spicer J, Harrington KJ and Pandha HS: HOX transcription
factors are potential targets and markers in malignant
mesothelioma. BMC Cancer. 16:852016. View Article : Google Scholar : PubMed/NCBI
|
18
|
Steger J, Füller E, Garcia-Cuellar MP,
Hetzner K and Slany RK: Insulin-like growth factor 1 is a direct
HOXA9 target important for hematopoietic transformation. Leukemia.
29:901–908. 2015. View Article : Google Scholar : PubMed/NCBI
|
19
|
Larsen BM, Hrycaj SM, Newman M, Li Y and
Wellik DM: Mesenchymal Hox6 function is required for mouse
pancreatic endocrine cell differentiation. Development.
142:3859–3868. 2015. View Article : Google Scholar : PubMed/NCBI
|
20
|
Chiba N, Comaills V, Shiotani B, Takahashi
F, Shimada T, Tajima K, Winokur D, Hayashida T, Willers H, Brachtel
E, et al: Homeobox B9 induces epithelial-to-mesenchymal
transition-associated radioresistance by accelerating DNA damage
responses. Proc Natl Acad Sci USA. 109:2760–2765. 2012. View Article : Google Scholar : PubMed/NCBI
|
21
|
Slany RK: MLL fusion proteins and
transcriptional control. Biochim Biophys Acta Gene Regul Mech.
1863:1945032020. View Article : Google Scholar : PubMed/NCBI
|
22
|
Cheng F, Liu J, Zhou SH, Wang XN, Chew JF
and Deng LW: RNA interference against mixed lineage leukemia 5
resulted in cell cycle arrest. Int J Biochem Cell Biol.
40:2472–2481. 2008. View Article : Google Scholar : PubMed/NCBI
|
23
|
Emerling BM, Bonifas J, Kratz CP, Donovan
S, Taylor BR, Green ED, Le Beau MM and Shannon KM: MLL5, a homolog
of Drosophila trithorax located within a segment of chromosome band
7q22 implicated in myeloid leukemia. Oncogene. 21:4849–4854. 2002.
View Article : Google Scholar : PubMed/NCBI
|
24
|
Lee KH, Kim BC, Jeong CW, Ku JH, Kim HH
and Kwak C: MLL5, a histone modifying enzyme, regulates androgen
receptor activity in prostate cancer cells by recruiting
co-regulators, HCF1 and SET1. BMB Rep. 53:634–639. 2020. View Article : Google Scholar : PubMed/NCBI
|
25
|
Madan V, Madan B, Brykczynska U,
Zilbermann F, Hogeveen K, Döhner K, Döhner H, Weber O, Blum C,
Rodewald HR, et al: Impaired function of primitive hematopoietic
cells in mice lacking the Mixed-Lineage-Leukemia homolog MLL5.
Blood. 113:1444–1454. 2009. View Article : Google Scholar : PubMed/NCBI
|
26
|
Heuser M, Yap DB, Leung M, de Algara TR,
Tafech A, McKinney S, Dixon J, Thresher R, Colledge B, Carlton M,
et al: Loss of MLL5 results in pleiotropic hematopoietic defects,
reduced neutrophil immune function, and extreme sensitivity to DNA
demethylation. Blood. 113:1432–1443. 2009. View Article : Google Scholar : PubMed/NCBI
|
27
|
Milne TA: MLL5 expression as a biomarker
for DNA hypermethylation and sensitivity to epigenetic therapy.
Haematologica. 99:1405–1407. 2014. View Article : Google Scholar : PubMed/NCBI
|
28
|
Zhou P, Wang Z, Yuan X, Zhou C, Liu L, Wan
X, Zhang F, Ding X, Wang C, Xiong S, et al: Mixed lineage leukemia
5 (MLL5) protein regulates cell cycle progression and
E2F1-responsive gene expression via association with host cell
factor-1 (HCF-1). J Biol Chem. 288:17532–17543. 2013. View Article : Google Scholar : PubMed/NCBI
|
29
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
30
|
Yan Y, Greer PM, Cao PT, Kolb RH and Cowan
KH: RAC1 GTPase plays an important role in gamma-irradiation
induced G2/M checkpoint activation. Breast Cancer Res. 14:R602012.
View Article : Google Scholar : PubMed/NCBI
|
31
|
Chen Z, Gao H, Dong Z, Shen Y, Wang Z, Wei
W, Yi J, Wang R, Wu N and Jin S: NRP1 regulates radiation-induced
EMT via TGF-β/Smad signaling in lung adenocarcinoma cells. Int J
Radiat Biol. 96:1281–1295. 2020. View Article : Google Scholar : PubMed/NCBI
|
32
|
Vanveldhuizen PJ, Zulfiqar M, Banerjee S,
Cherian R, Saxena NK, Rabe A, Thrasher JB and Banerjee SK:
Differential expression of neuropilin-1 in malignant and benign
prostatic stromal tissue. Oncol Rep. 10:1067–1071. 2003.PubMed/NCBI
|
33
|
Pawlik TM and Keyomarsi K: Role of cell
cycle in mediating sensitivity to radiotherapy. Int J Radiat Oncol
Biol Phys. 59:928–942. 2004. View Article : Google Scholar : PubMed/NCBI
|